What this risk is, and why it matters
Personal director exposure is the risk that a claim reaches an individual director's own assets and reputation, not just the company's. Directors-and-officers cover is designed to protect against this, but it is conditional, heavily exclusioned, and can be eroded by company indemnity limits, insolvency or conduct carve-outs. For a director, the concern is discovering mid-crisis that personal protection is narrower or more contested than assumed, leaving genuine individual exposure where cover was expected.
Legal and regulatory framework
Personal exposure flows from directors' statutory and fiduciary duties, the limits on company indemnification, and the structure of D&O cover, including the Side A protection that responds when the company cannot indemnify. Insolvency and regulatory investigations frequently test these boundaries. The report explains how directors-duties and D&O frameworks shape personal exposure in your chosen jurisdiction and industry as research, and not as advice to any individual director.
Typical scenarios and impact
Scenarios include regulatory investigations, shareholder or creditor claims, and insolvency proceedings where company indemnity is unavailable and Side A cover becomes critical. Impact on an individual can range from defence costs to personal liability for substantial sums, alongside reputational and career consequences. Where cover is exhausted by earlier claims, eroded by exclusions, or denied for conduct, a director may face exposure with no effective protection at the moment it is most needed.
Mitigation framework and when to engage an expert
Directors should understand their personal cover independently of the company's reassurances: confirm Side A and non-rescindable protections, review exclusions and limits, and check that indemnification and insurance are properly aligned. Brokers can structure dedicated individual protection, and personal coverage counsel should be available where an investigation or claim names the director. Treat D&O adequacy as a standing board agenda item, not an assumption, particularly where insolvency or regulatory risk is rising.